Michel Perez

E5531, a Pure Endotoxin Antagonist of High Potency

William J. Christ, Osamu Asano, Andrea L. C. Robidoux et al. · Science · 1995 · 321 citations

Pharmacotherapy, Viable Escherichia Coli, Drug Resistance +16

Antibody-drug conjugate model fast characterization by LC-MS following IdeS proteolytic digestion

Elsa Wagner‐Rousset, Marie-Claire Janin-Bussat, Olivier Colas et al. · mAbs · 2013 · 122 citations · Full text

Selenium-mediated glycosidations: A selective synthesis of β-2-deoxyglycosides

Michel Perez, Jean‐Marie Beau · Tetrahedron Letters · 1989 · 102 citations

Bioorganic Chemistry, Biochemistry, Selenium Deficiency +4

Total Synthesis of the Proposed Structure of Rhodobacter sphaeroides Lipid A Resulting in the Synthesis of New Potent Lipopolysaccharide Antagonists

William J. Christ, Pamela D. McGuinness, Osamu Asano et al. · Journal of the American Chemical Society · 1994 · 87 citations

Lipid Analysis, Bioorganic Chemistry, Altmetric Attention Score +18

Serotonin Dimers:  Application of the Bivalent Ligand Approach to the Design of New Potent and Selective 5-HT_1B/1D Agonists

Serge Halazy, Michel Perez, Catherine Fourrier et al. · Journal of Medicinal Chemistry · 1996 · 61 citations · Full text

Formula 4, Pharmacotherapy, Chemistry +19